The Inhibitory Effect of Human Beta-defensin-3 on Candida Glabrata Isolated from Patients with Candidiasis

References

• Arendrup MC, Patterson TF. 2017. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 216:S445–S451.
   PubMed Web of Science ®Google Scholar
• Berkow EL, Lockhart SR. 2017. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist. 10:237–45.
   PubMed Web of Science ®Google Scholar
• Bobone S. 2014. Peptide and protein interaction with membrane systems: applications to antimicrobial therapy and protein drug delivery. Switzerland: Springer International Publishing.
   Google Scholar
• Campitelli M, Zeineddine N, Samaha G, Maslak S. 2017. Combination antifungal therapy: a review of current data. J Clin Med Res. 9:451–56.
   PubMedGoogle Scholar
• Chaturvedi V, Ramani R, Andes D, Diekema DJ, Pfaller MA, Ghannoum MA, Knapp C, Lockhart SR, Ostrosky-Zeichner L, Walsh TJ, et al. 2011. Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrob Agents Chemother. 55:1543–48.
   PubMed Web of Science ®Google Scholar
• Denardi LB, Keller JT, Oliveira V, Mario DAN, Santurio JM, Alves SH. 2017. Activity of combined antifungal agents against multidrug-resistant Candida glabrata strains. Mycopathologia. 182:819–28.
   PubMed Web of Science ®Google Scholar
• Déry M, Hasbun R. 2011. Fluconazole-resistant Candida: mechanisms and risk factor identification. Curr Fungal Infect Rep. 5:23–28.
   Google Scholar
• Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M. 2012. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis. 73:45–48.
   PubMed Web of Science ®Google Scholar
• Guinea J. 2014. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 20(Suppl 6):5–10.
   Web of Science ®Google Scholar
• Hancock RE, Haney EF, Gill EE. 2016. The immunology of host defence peptides: beyond antimicrobial activity. Nat Rev Immunol. 16:321–34.
   PubMed Web of Science ®Google Scholar
• Healey KR, Jimenez Ortigosa C, Shor E, Perlin DS. 2016. Genetic drivers of multidrug resistance in Candida glabrata. Front Microbiol. 7:1995.
   PubMed Web of Science ®Google Scholar
• Hollmann A, Martinez M, Maturana P, Semorile LC, Maffia PC. 2018. Antimicrobial peptides: interaction with model and biological membranes and synergism with chemical antibiotics. Front Chem. 6:204.
   PubMed Web of Science ®Google Scholar
• Institute, CaLS. 2017. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard Fourth ed. CLSI document M27-A3. Pennsylvania (USA): Wayne.
   Google Scholar
• Joly S, Maze C, McCray PB Jr., Guthmiller JM. 2004. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol. 42:1024–29.
   PubMed Web of Science ®Google Scholar
• Krishnakumari V, Rangaraj N, Nagaraj R. 2009. Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3. Antimicrob Agents Chemother. 53:256–60.
   PubMed Web of Science ®Google Scholar
• Kullberg BJ, Arendrup MC. 2015. Invasive candidiasis. N Engl J Med. 373:1445–56.
   PubMed Web of Science ®Google Scholar
• Lipke PN, Ovalle R. 1998. Cell wall architecture in yeast: new structure and new challenges. J Bacteriol. 180:3735–40.
   PubMed Web of Science ®Google Scholar
• Lockhart SR. 2014. Current epidemiology of Candida infection. Clin Microbiol Newsl. 36:131–36.
   Google Scholar
• Marr AK, Gooderham WJ, Hancock RE. 2006. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol. 6:468–72.
   PubMed Web of Science ®Google Scholar
• Maturana P, Martinez M, Noguera ME, Santos NC, Disalvo EA, Semorile L, Maffia PC, Hollmann A. 2017. Lipid selectivity in novel antimicrobial peptides: implication on antimicrobial and hemolytic activity. Colloids Surf B Biointerfaces. 153:152–59.
   PubMed Web of Science ®Google Scholar
• McCarty TP, Pappas PG. 2016. Invasive candidiasis. Infect Dis Clin North Am. 30:103–24.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. 2018. Invasive candidiasis. Nat Rev Dis Primers. 4:18026.
   PubMed Web of Science ®Google Scholar
• Pasupuleti M, Schmidtchen A, Malmsten M. 2012. Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol. 32:143–71.
   PubMed Web of Science ®Google Scholar
• Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J. 2006. Human beta-defensins. Cell Mol Life Sci. 63:1294–313.
   PubMed Web of Science ®Google Scholar
• Posteraro B, Efremov L, Leoncini E, Amore R, Posteraro P, Ricciardi W, Sanguinetti M. 2015. Are the conventional commercial yeast identification methods still helpful in the era of new clinical microbiology diagnostics? A meta-analysis of their accuracy. J Clin Microbiol. 53:2439–50.
   PubMed Web of Science ®Google Scholar
• Schneider JJ, Unholzer A, Schaller M, Schafer-Korting M, Korting HC. 2005. Human defensins. J Mol Med (Berl). 83:587–95.
   PubMed Web of Science ®Google Scholar
• Scorzoni L, de Paula ESAC, Marcos CM, Assato PA, de Melo WC, de Oliveira HC, Costa-Orlandi CB, Mendes-Giannini MJ, Fusco-Almeida AM. 2017. Antifungal therapy: new advances in the understanding and treatment of mycosis. Front Microbiol. 8:36.
   PubMed Web of Science ®Google Scholar
• Shrestha SK, Fosso MY, Garneau-Tsodikova S. 2015a. A combination approach to treating fungal infections. Sci Rep. 5:17070.
   PubMed Web of Science ®Google Scholar
• Shrestha SK, Grilley M, Anderson T, Dhiman C, Oblad J, Chang C-WT, Sorensen KN, Takemoto JY. 2015b. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans. Med Mycol. 53:837–44.
   PubMed Web of Science ®Google Scholar
• Silva PM, Goncalves S, Santos NC. 2014. Defensins: antifungal lessons from eukaryotes. Front Microbiol. 5:97.
   PubMed Web of Science ®Google Scholar
• Sudheendra US, Dhople V, Datta A, Kar RK, Shelburne CE, Bhunia A, Ramamoorthy A. 2015. Membrane disruptive antimicrobial activities of human beta-defensin-3 analogs. Eur J Med Chem. 91:91–99.
   PubMed Web of Science ®Google Scholar
• Tan BH, Chakrabarti A, Li RY, Patel AK, Watcharananan SP, Liu Z, Chindamporn A, Tan AL, Sun PL, Wu UI, et al. 2015. Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect. 21:946–53.
   PubMed Web of Science ®Google Scholar
• Valenza G, Strasen J, Schafer F, Frosch M, Kurzai O, Abele-Horn M. 2008. Evaluation of new colorimetric vitek 2 yeast identification card by use of different source media. J Clin Microbiol. 46:3784–87.
   PubMed Web of Science ®Google Scholar
• Vale-Silva LA, Sanglard D. 2015. Tipping the balance both ways: drug resistance and virulence in Candida glabrata. FEMS Yeast Res. 15:1–8.
   Web of Science ®Google Scholar
• Wang G. 2008. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem. 283:32637–43.
   PubMed Web of Science ®Google Scholar
• Wang G. 2014. Human antimicrobial peptides and proteins. Pharmaceuticals. 7:545–94.
   Google Scholar
• Wang T, Shao J, Da W, Li Q, Shi G, Wu D, Wang C. 2018. Strong synergism of palmatine and fluconazole/itraconazole against planktonic and biofilm cells of Candida species and efflux-associated antifungal mechanism. Front Microbiol. 9:2892.
   PubMed Web of Science ®Google Scholar